Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans

NCT06940895 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Acanthosis Nigricans

Interventions

DRUG: Sirolimus 0.2%

Sponsor

Narrows Institute for Biomedical Research

Collaborators

[object Object]